GO
Loading...

Takeover Bids

More

  • Faber Report: Sprint Gains Control of Clearwire  Thursday, 18 Oct 2012 | 9:40 AM ET

    CNBC's David Faber reports the latest detail on Sprint's takeover of Clearwire; and weighs in on Verizon's earnings.

  • Ellison Eyeing the Lakers?  Friday, 12 Oct 2012 | 4:43 PM ET

    CNBC's Robert Frank says Ellison's reported interest in bidding on AEG, which owns a piece of the Lakers, is in very preliminary stages. Mark Martiak, Premier Wealth Management, provides perspective.

  • Ackman: P&G Has Stumbled Over Past Few Years  Tuesday, 2 Oct 2012 | 7:40 AM ET

    P&G has been one of the great growth companies of all times but quite frankly it has stumbled over the past couple of years under the current CEO's leadership, said William Ackman, Pershing Square Capital Management founder & CEO, discussing the problems at Procter & Gamble.

  • Ackman: P&G 'Stumbled' Under McDonald's Leadership  Tuesday, 2 Oct 2012 | 7:40 AM ET

    In this excerpt from a "Squawk Box" interview on October 2, 2012, Pershing Square's Bill Ackman said he had bought some stock and expressed his concerns about the company to its Board.

  • Equity Firms Like Bain Are Depicted as Colluding Wednesday, 12 Sep 2012 | 10:01 AM ET
    Bain Capital headquarters, Bostonb Mass.

    In court documents that lawyers for Bain Capital sought to keep secret, the company and other leading private equity firms are depicted as unofficial partners in a bid-rigging conspiracy aimed at holding down the prices of businesses they were seeking to buy, The New York Times reports.

  • Finding Value in Health Care Stocks  Monday, 10 Sep 2012 | 8:57 AM ET

    Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to play the health care space.

  • Short Regional Banks: Singh  Monday, 10 Sep 2012 | 8:41 AM ET

    Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to trade financials after the banking crisis.

  • Does QE3 Really Matter?  Monday, 10 Sep 2012 | 8:03 AM ET

    "Ultimately, I don't think lower rates make that much difference anymore," says Dinakar Singh, TPG-Axon Capital CEO, sharing his thoughts on additional Fed easing.

  • Featured Speaker - Henry R. Kravis Monday, 16 Jul 2012 | 12:04 PM ET
    Henry R. Kravis, Co-Chairman and Co-CEO, KKR

    The co-founder of the trailblazing private-equity firm Kohlberg Kravis Roberts is actively involved in managing the firm famous for its leveraged buyout of RJR Nabisco 25 years ago.

  • Faber Report: GSK's Acquires Human Genome Science  Monday, 16 Jul 2012 | 9:42 AM ET

    CNBC's David Faber reports the latest details on GlaxoSmithKline's takeover bid for Human Genome Science.

  • Five Stocks Ripe for Takeovers? Tuesday, 10 Jul 2012 | 8:49 AM ET

    Here are five companies that could be bought, according to analyst Ken Hackel of CT Capital, best known for his book, “Security Valuation and Risk Analysis.”

  • $7.1 Billion Pharma Deal  Monday, 2 Jul 2012 | 1:11 PM ET

    CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.

  • Deal Brewing Between Grupo Modelo and Anheuser  Monday, 25 Jun 2012 | 11:50 AM ET

    CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.

  • What's Next for Carl Icahn?  Monday, 30 Apr 2012 | 4:14 PM ET

    CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.

  • Human Genome Rejects GlaxoSmithKline's Bid  Thursday, 19 Apr 2012 | 12:41 PM ET

    Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.

  • Illumina Plays Offense & Final Trade  Tuesday, 17 Apr 2012 | 12:55 PM ET

    CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.

  • Faber Report: Illumina  Tuesday, 17 Apr 2012 | 9:42 AM ET

    CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.

  • Mad Money host Jim Cramer shares his final thoughts on the future of tech giants, Research in Motion and Yahoo.

  • Avon for Sale?  Monday, 2 Apr 2012 | 5:17 PM ET

    The Fast Money traders weigh in on how to play unusual options activity in Avon's shares on Monday.

  • Groupon Revises Q4 & Full Year  Monday, 2 Apr 2012 | 3:09 PM ET

    CNBC's Brian Shactman breaks down today's big movers including two downgrades at Stifel Nicolaus, and Avon's rejection of a takeover bid from Coty.